据港交所9月4日披露，健康160国际有限公司(以下简称：健康160)通过港交所主板上市聆讯，申万宏源 香港、清科资本为其联席保荐人。 据招股书，健康160是富有经验的中国医药健康用品批发商及领先的数字医疗综合服务提供商。该公司 为客户提供各种医药健康用品，以及全面的数字医疗健康解决方案。在批发及零售模式下，提供一系列 优质的医药健康用品，以满足客户的不同需求。此外，该公司亦通过在线医疗健康服务平台-健康160平 台提供数字医疗健康解决方案，赋能整个医疗健康产业链上的各平台参与方(主要包括企业客户、医疗 卫生机构、医护人员及个人用户和第三方商户)，推动中国医疗健康行业的数字化转型。 在提供数字化医疗健康解决方案时，该公司已开发健康160平台，该服务平台通过整合在线及线下渠道 的医疗健康服务，有效地连接医疗健康机构，医护人员及个人用户。平台提供多样化的医疗健康服务， 包括严肃医疗及消费医疗服务。该公司对数字医疗健康解决方案中采用有效的变现策略，来从各平台参 与方产生收入，从而构成该公司的重要收入来源。根据弗若斯特沙利文的资料，按2024年通过平台挂号 的数量计算;截至2024年12月31日合作医院数量计算;截至2 ...

Core Viewpoint - The strategic partnership between Weimai and Alibaba Cloud aims to leverage AI technology to drive digital transformation in the healthcare industry, addressing the need for improved service quality and efficiency during this critical transition period [1][2]. Group 1: Partnership Details - Weimai and Alibaba Cloud signed a strategic cooperation agreement on August 19, focusing on integrating healthcare scene advantages with AI technology strengths [1]. - The collaboration will involve joint efforts in developing AI applications specifically for the healthcare sector, emphasizing intelligent analysis and processing of multimodal medical data [2]. Group 2: Technological Focus - The partnership will explore commercial pathways for AI technology in key medical scenarios such as disease management, precision diagnosis, and public health warning systems [2]. - The "Full Cycle FSD" intelligent model promoted by both companies aims to address issues in traditional disease management by integrating data, algorithm-assisted decision-making, and human-machine collaboration [2]. Group 3: Leadership Insights - Weimai's CEO Qiu Jialin stated that the goal is to dynamically optimize the entire health management process, shifting from "passive treatment" to "active safeguarding" [2]. - Alibaba Cloud's Vice President Li Gang expressed intentions to explore more possibilities in smart healthcare solutions, aiming to create a scalable new model for intelligent healthcare [2].